Fundraising Fox
/People
Sign in

Nicolas Favre

Investor

Chief Business Officer, Business Development & Commercial at Debiopharm Innovation Fund

London, England, United Kingdom

Find your path to Nicolas

195 people in our graph can introduce you to Nicolas.

Sign up to see every warm intro you have to Nicolas

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Nicolas. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

About

Chief Business Officer overseeing Commercial and Business Development. He joined Debiopharm in 2016 and previously held R&D and marketing roles at Merck Serono, Lundbeck and Novo Nordisk. He holds a PhD from the University of Geneva and an MBA.

Experience

  1. DebiopharmChief Business Officercurrent2023 — presentLausanne, Vaud, Switzerland
  2. DebiopharmSenior Executive Director, Business Develoment & Commercial2021 — 2023Lausanne, Vaud, Switzerland
  3. DebiopharmExecutive Director, Head of Marketing, Market Access & Medical Affairs2020 — 2021Lausanne, Vaud, Switzerland
  4. DebiopharmExecutive Director, Head of Marketing & Market Access2019 — 2020
  5. DebiopharmHead of Marketing & Market Access2018 — 2020Lausanne, Canton of Vaud, Switzerland
  6. DebiopharmHead of Marketing2016 — 2018Lausanne, Vaud, Switzerland
  7. Novo NordiskSenior Global Product Manager, Levemir2013 — 2016Copenhagen Metropolitan Area
  8. LundbeckGlobal Brand Manager, Azilect2011 — 2013Copenhagen Metropolitan Area
  9. Brand InstitutePresident, Brand Development - Geneva2009 — 2011
  10. Brand InstituteDirector, Brand Development2009
  11. Aardex GroupEMEA Product Manager2007 — 2008
  12. Aardex GroupSales & Marketing Manager2006 — 2007
  13. Merck SeronoProject Manager, R&D Signal Transduction2002 — 2005
  14. Merck SeronoProject Manager, R&D, Screening Department2000 — 2001

Skills & more

Corporate Business DevelopmentOncology, CNS, MetabolismGlobal Commercial StrategyCommercial ManagementProduct MarketingMarket AccessMarket IntelligenceCommercial strategyCustomer centricityCommunicationValue PropositionsBrand Development7
+12 moreGlobal MarketingMarketing StrategyProduct LaunchesMarketing ManagementPublic RelationsCongressMarket ResearchPharmaceutical IndustryBrand ManagementSegmentationProduct Lifecycle ManagementOnline Marketing

Languages English · French · German

From Nicolas's professional profile.

Colleagues at Debiopharm Innovation Fund

Angela Zubel
Chief Development Officer, Research & Development at Debiopharm Innovation Fund
Bertrand Ducrey
Chief Executive Officer, Debiopharm International & Senior Vice-Chairman, Debiopharm at Debiopharm Innovation Fund
Cedric Odje
Investment Associate at Debiopharm Innovation Fund
Chris Thomas
Director, Investments at Wollemi Capital
Dawid Książczak
Chief Legal Officer at McWin Capital Partners
Frédéric Lévy
Chief Scientific Officer, Search & Evaluation and Scientific Innovation at Debiopharm Innovation Fund
Kavita Patel
Principal at Muus Climate Partners
Kerstin Planitzer-Zipf
Chief Compliance Officer at Cipio Partners

Frequently asked questions

Who is Nicolas Favre?
Chief Business Officer overseeing Commercial and Business Development. He joined Debiopharm in 2016 and previously held R&D and marketing roles at Merck Serono, Lundbeck and Novo Nordisk. He holds a PhD from the University of Geneva and an MBA.
Where does Nicolas Favre work?
Nicolas Favre is Chief Business Officer, Business Development & Commercial at Debiopharm Innovation Fund.
Where did Nicolas Favre go to school?
Nicolas Favre studied at OU Business School (MBA, International Marketing); University of Geneva (Ph.D., Biology and Biotechnology); Lycée Collège des Creusets (High School, Economy).

Same school

Shared employers